Pan-tumor analyses of kinase fusions detected in circulating tumor DNA (ctDNA) and concordance with paired tissue.

被引：0
|
作者：
Lee, Jessica Kim
Lieber, Daniel
Madison, Russell
Chung, Jon
Schrock, Alexa Betzig
Creeden, James
Venstrom, Jeffrey
Alexander, Brian Michael
Hazar-Rethinam, Mehlika
机构：
[1] Fdn Med Inc, Cambridge, MA USA
[2] Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3517
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Genetic alterations detected by circulating tumor DNA (ctDNA) in HER2-low metastatic breast cancer (MBC)
    Hensing, Whitney L.
    Gerratana, Lorenzo
    Clifton, Katherine
    Velimirovic, Marko
    Shah, Ami
    D'Amico, Paolo
    Reduzzi, Carolina
    Zhang, Qiang
    Dai, Charles S.
    Bagegni, Nusayba A.
    Opyrchal, Mateusz
    Ademuyiwa, Foluso O.
    Ron, Bose
    Behdad, Amir
    Ma, Cynthia X.
    Bardia, Aditya
    Cristofanilli, Massimo
    Davis, Andrew A.
    CANCER RESEARCH, 2022, 82 (04)
  • [42] The landscape of genomic alterations detected in serial circulating tumor DNA (ctDNA) in clinical progressive metastatic breast cancer.
    Jacob, Saya
    Davis, Andrew A.
    Gerratana, Lorenzo
    Shah, Ami N.
    Katam, Neelima
    Zhang, Qiang
    Wehbe, Firas
    Flaum, Lisa E.
    Siziopikou, Kalliopi P.
    Platanias, Leonidas C.
    Gradishar, William John
    Behdad, Amir
    Cristofanilli, Massimo
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [43] The concordance between circulating tumor DNA and tissue genomic profiling in patients with advanced biliary tract cancer
    Woo, S.
    Hwang, S.
    Kim, G.
    Kang, H.
    Kyung, D. S.
    Lee, W.
    Kim, H-P.
    Kang, B.
    Kim, C.
    Chon, H. J.
    ANNALS OF ONCOLOGY, 2023, 34 : S223 - S224
  • [44] Pan-cancer assessment of BRCA1/2 genomic alterations (GAs) by comprehensive genomic profiling (CGP) of tissue and circulating tumor DNA (ctDNA)
    Agarwal, N.
    Sokol, E. S.
    Lara, P., Jr.
    Ross, J. S.
    Miller, V. A.
    Welsh, A. W.
    Gregg, J. P.
    Frampton, G. M.
    Ali, S. M.
    Chung, J.
    ANNALS OF ONCOLOGY, 2018, 29
  • [45] Comprehensive landscape of gene amplifications (amps) in tissue and circulating tumor DNA (ctDNA) in metastatic colorectal cancer (mCRC).
    Raghav, Kanwal Pratap Singh
    Yaeger, Rona
    Loree, Jonathan M.
    Dasari, Arvind
    Morris, Van K.
    Kee, Bryan K.
    Raymond, Victoria M.
    Nagy, Rebecca J.
    Lanman, Richard B.
    Strickler, John H.
    Corcoran, Ryan Bruce
    Overman, Michael J.
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [46] Re: Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2018, 199 (06): : 1396 - 1397
  • [47] Concordance of mutations identified using circulating tumor DNA (ctDNA) compared to tissue based next generation sequencing (NGS) in gastrointestinal malignancies: A single institution experience.
    Kamath, Suneel Deepak
    Kalyan, Aparna
    Taxter, Timothy J.
    Wehbe, Firas
    Kircher, Sheetal Mehta
    Nimeiri, Halla Sayed
    Mulcahy, Mary Frances
    Benson, Al Bowen
    Cristofanilli, Massimo
    Giles, Francis J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [48] Concordance and Clinical Significance of Genomic Alterations in Progressive Tumor Tissue and Matched Circulating Tumor DNA in Aggressive-variant Prostate Cancer
    Wang, Ruiliang
    Xu, Qiufan
    Guo, Hanxu
    Yang, Guanjie
    Zhang, Jun
    Wang, Hong
    Xu, Tianyuan
    Guo, Changcheng
    Yuan, Jing
    He, Yanyan
    Zhang, Xiaoying
    Fu, Hongliang
    Xu, Guang
    Zhao, Binghui
    Xie, Jun
    Zhao, Tingting
    Huang, Longfei
    Zhang, Jiansheng
    Peng, Bo
    Yao, Xudong
    Yang, Bin
    CANCER RESEARCH COMMUNICATIONS, 2023, 3 (11): : 2221 - 2232
  • [49] Assessment of circulating cell-free tumor DNA (ctDNA) in 847 patients (pts) with metastatic renal cell carcinoma (mRCC) and concordance with tissue-based testing
    Zengin, Z. B.
    Weipert, C.
    Hsu, J.
    Salgia, N.
    Saam, J.
    Choueiri, T. K.
    Agarwal, N.
    Pal, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S553 - S554
  • [50] Circulating tumor DNA (ctDNA) analyses of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor (GIST).
    Serrano, Cesar
    Bauer, Sebastian
    Gomez-Peregrina, David
    Kang, Yoon-Koo
    Jones, Robin L.
    Rutkowski, Piotr
    Mir, Olivier
    Heinrich, Michael C.
    Tap, William D.
    Newberry, Kate
    Grassian, Alexandra
    Miller, Stephen G.
    Shi, Hongliang
    Schoffski, Patrick
    Pantaleo, Maria A.
    Von Mehren, Margaret
    Trent, Jonathan C.
    George, Suzanne
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345